Skip to content

A randomized controlled trial on acupuncture treatment of diarrheal-predominant irritable bowel syndrome

A randomized controlled trial on acupuncture treatment of diarrheal-predominant irritable bowel syndrome

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100004642
Enrollment
Unknown
Registered
2021-03-26
Start date
2021-04-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irritable bowel syndrome

Interventions

Sham acupuncture group:Acupuncture non-acupoints for 6 weeks, a total of 15 times

Sponsors

Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged between 18 and 75 years (no gender limitation); 2. Meets the diagnostic criteria of diarrheal-predominant irritable bowel syndrome (IBS-D); 3. Type 6 or 7 of the Bristol Stool Form Scale appeared for at least 4 days and type 1 or 2 appeared for less than 4 days in last 2 weeks; The average score of daily abdominal pain was >= 3 in the last week; 4. No treatment of acupuncture in the last 6 months; 5. No use of antidepressant or IBS medication within 2 weeks before treatment, including traditional Chinese medicine (TCM) or proprietary Chinese medicine, antidiarrheal, antispasmodic, intestinal antibiotics, probiotics and so on.

Exclusion criteria

Exclusion criteria: 1.Patients with the following diseases: inflammatory bowel disease, microscopic colitis, celiac disease, Crohn's disease and other organic bowel diseases; 2.Diabetes mellitus and abnormal thyroid function; 3.Severe acute or chronic organic diseases, kidney or liver diseases; 4.History of abdominal surgery (appendectomy, hemorrhoidectomy, or polypectomy greater than 3 months post-surgery are allowed.); 5.Pregnancy or lactation; 6.History of alcohol and drug abuse; 7.Participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Effective response rate;

Secondary

MeasureTime frame
IBS symptom severity scale, IBS-SSS;defecation frequency;Symptoms of bloating;Effective response rate at other time points;Symptoms of abdominal pain;Quality of life questionnaire, IBS-QOL;IBS-AR;Patient Health Questionnaire Depression Scale;

Countries

China

Contacts

Public ContactLiu Cunzhi

School of Acupuncture-Moxibustion and Tuina, Beijing University of Chinese Medicine

lcz_tg@126.com+86 10 53912201

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026